Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by L Besse
Proteasome Inhibitor-Adapted Myeloma Cells Are Largely Independent From Proteasome Activity and Show Complex Proteomic Changes, in Particular in Redox and Energy Metabolism
Leukemia
Cancer Research
Oncology
Anesthesiology
Pain Medicine
Hematology
Carfilzomib Resistance Due to ABCB1/MDR1 Overexpression Is Overcome by Nelfinavir and Lopinavir in Multiple Myeloma
Leukemia
Cancer Research
Oncology
Anesthesiology
Pain Medicine
Hematology
Related publications
Myeloma Cells Exhibit an Increase in Proteasome Activity and an Enhanced Response to Proteasome Inhibition in the Bone Marrow Microenvironment in Vivo
American Journal of Hematology
Hematology
Xbp1s-Negative Tumor B Cells and Pre-Plasmablasts Mediate Therapeutic Proteasome Inhibitor Resistance in Multiple Myeloma
Cancer Cell
Cancer Research
Oncology
Cell Biology
A Metabolic Switch in Proteasome Inhibitor-Resistant Multiple Myeloma Ensures Higher Mitochondrial Metabolism, Protein Folding and Sphingomyelin Synthesis
Haematologica
Hematology
Investigating Effects of Proteasome Inhibitor on Multiple Myeloma Cells Using Confocal Raman Microscopy
Sensors
Instrumentation
Information Systems
Electronic Engineering
Biochemistry
Analytical Chemistry
Molecular Physics,
Electrical
Atomic
Medicine
Optics
Sensitizing Human Multiple Myeloma Cells to the Proteasome Inhibitor Bortezomib by Novel Curcumin Analogs
International Journal of Molecular Medicine
Medicine
Genetics
Role for Proteasome Activator PA200 and Postglutamyl Proteasome Activity in Genomic Stability
Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
Thiasyrbactins Induce Cell Death via Proteasome Inhibition in Multiple Myeloma Cells
Anticancer Research
Medicine
Cancer Research
Oncology
Resistance to Proteasome Inhibitors and Other Targeted Therapies in Myeloma
British Journal of Haematology
Hematology
Nelfinavir Augments Proteasome Inhibition by Bortezomib in Myeloma Cells and Overcomes Bortezomib and Carfilzomib Resistance
Blood Cancer Journal
Oncology
Hematology
